The Soaring Cost of Brand-Name Drugs

Seniors are paying more for name-brand drugs, while getting fewer of them, according to a new government report that also notes Medicare spending on name-brand drugs rose by 77 percent over five years, even as usage fell. Economics Associate Professor of the Practice Sam Richardson weighs in for NBCNews.com.